There is hard data to show that newborn infants are more likely than adults to experience adverse reactions to drugs. Paradoxically, drug-related legislation to ensure safe and effective drug use in humans neglected neonates until 2002, when the Best Pharmaceuticals Act for Children was signed into law in the USA. The situation for neonates should now catch up with that for adults and neonates will be prescribed more licensed drugs in the near future. If we are to be able to analyze the underlying system errors to improve the safe use of drugs in the studied patient population, reporting of adverse drug events and reactions needs to happen in a blame free environment. In addition, computerized physician order entry will certainly further improve the current situation by preventing errors in ordering, transcribing, verifying, and transmitting medication orders.

, , , , ,,
Seminars in Fetal & Neonatal Medicine
Department of Pediatrics

van den Anker, J.N. (2005). Managing drugs safely. Seminars in Fetal & Neonatal Medicine (Vol. 10, pp. 73–81). doi:10.1016/j.siny.2004.09.005